Time: June 14, 2021 at 16.00-18.15 EEST
Place: zoom webinar (link sent to registered participants)

16.00 – 16.10
Opening words

16.10 – 16.45
Stéphanie Lheureux, MD, PhD,
Princess Margaret Cancer Centre, Toronto, Canada:
Rethinking ovarian cancer

16.45 – 17.05
Johanna Hynninen, MD, PhD
Turku University Hospital, Finland:
How to maintain a clinical cancer cohort and retain one´s sanity in a
translational research consortium

17.05 – 17.25
Krister Wennerberg
University of Copenhagen, Denmark & University of Helsinki, Finland:
Studying ovarian cancer drug resistance in vitro

17.25 – 17.45
Anna Vähärautio
University of Helsinki, Finland:
How does NACT modify the gene expression of ovarian tumors?
Perspective of single cells

17.45 – 18.05
Sampsa Hautaniemi,
University of Helsinki, Finland:
Genetic changes during ovarian cancer treatment

18.05 – 18.15
Conclusions and closing words